Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Orthopediatrics (KIDS) Revenue (2016 - 2025)

Historic Revenue for Orthopediatrics (KIDS) over the last 10 years, with Q3 2025 value amounting to $61.2 million.

  • Orthopediatrics' Revenue rose 1223.5% to $61.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $227.4 million, marking a year-over-year increase of 1989.58%. This contributed to the annual value of $204.7 million for FY2024, which is 3764.83% up from last year.
  • Per Orthopediatrics' latest filing, its Revenue stood at $61.2 million for Q3 2025, which was up 1223.5% from $61.1 million recorded in Q2 2025.
  • Over the past 5 years, Orthopediatrics' Revenue peaked at $61.2 million during Q3 2025, and registered a low of $21.5 million during Q1 2021.
  • Moreover, its 5-year median value for Revenue was $37.6 million (2023), whereas its average is $39.4 million.
  • In the last 5 years, Orthopediatrics' Revenue skyrocketed by 9638.78% in 2021 and then surged by 910.91% in 2022.
  • Over the past 5 years, Orthopediatrics' Revenue (Quarter) stood at $24.8 million in 2021, then increased by 24.91% to $31.0 million in 2022, then grew by 21.36% to $37.6 million in 2023, then skyrocketed by 40.02% to $52.7 million in 2024, then grew by 16.3% to $61.2 million in 2025.
  • Its Revenue was $61.2 million in Q3 2025, compared to $61.1 million in Q2 2025 and $52.4 million in Q1 2025.